Cell Counting Market Report 2026

Cell Counting Market Overview

• Cell Counting market size has reached to $11.39 billion in 2025 • Expected to grow to $17.83 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling Growth In The Cell Counting Market • Market Trend: Innovative Breakthrough Bd Facsdiscover S8 Spectral Cell Sorter Revolutionizes Cell Counting Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Counting Market?

Cell counting refers to any of techniques used for counting cells or quantification of cells in the life sciences for diagnosis and treatment. Cell counting is used in monitoring cell health and proliferation rate assessing immortalization or transformation, transfection or infection, seeding cells for subsequent experiments, and preparing for cell-based assays. The main consumables and accessories used in cell counting are media, sera and reagents, assay kits, microplates, accessories and other consumables. Media, sera and reagents are used as a part of cell culture and have applications in cancer research, development of biopharmaceuticals, regenerative medicine, and other research purposes. Various products include spectrophotometers, single-mode readers, multi-mode readers, cell counters, automated cell counters, hemocytometers, manual cell counters, flow cytometers and hematology analyzers. Cell counting is majorly used in for research applications, clinical and diagnostic applications and industrial applications and the end-user include hospitals and diagnostic, research institutions, pharmaceutical and biotechnology companies and others.

What Is The Cell Counting Market Growth Forecast?

The cell counting market size is expected to see strong growth in the next few years. It will grow to $17.83 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for cell-based therapies, rising adoption of precision diagnostics, expansion of biotechnology research pipelines, growing use of ai-enabled laboratory analytics, increasing focus on standardized laboratory workflows. Major trends in the forecast period include increasing adoption of automated cell counting systems, rising use of flow cytometry-based cell analysis, growing demand for high-throughput cell counting, expansion of cell-based research applications, enhanced focus on data accuracy and reproducibility.

Global Cell Counting Market Segmentation

1) By Consumables And Accessories: Media, Sera And Reagents, Assay Kits, Microplates 2) By Product: Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers 3) By Application: Research Applications, Clinical And Diagnostic Applications, Industrial Applications 4) By End-User: Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Media: Cell Culture Media, Specialized Growth Media 2) By Sera and Reagents: Fetal Bovine Serum (FBS), Human Serum, Reagents for Cell Viability 3) By Assay Kits: Cell Counting Kits, Apoptosis Detection Kits 4) By Microplates: 96-Well Plates, 384-Well Plates, Specialized Cell Culture Plates

What Is The Driver Of The Cell Counting Market?

The rising prevalence of chronic diseases is expected to propel the growth of the cell counting market in the coming years. Chronic diseases are defined as issues that last a year or longer and need ongoing medical care, interfere with daily activities, or both. Chronic diseases involve complex etiologies, multiple risk factors, lengthy incubation periods, extended illness, and reduced function or impairment. Cell counting is an important diagnostic, monitoring, and therapy technique for chronic illnesses. It assists healthcare workers in detecting and monitoring alterations in cell counts, which can give significant information regarding disease progression and therapy effectiveness. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the cell counting industry.

Key Players In The Global Cell Counting Market

Major companies operating in the cell counting market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Olympus Corporation, HORIBA Ltd., Logos Biosystems Inc., Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., BioTek Instruments Inc., DeNovix Inc., Sysmex Corporation, Nexcelom Bioscience LLC, Beckman Coulter Inc., Roche Diagnostics International Ltd., Miltenyi Biotec GmbH, AccuBioTech Co. Ltd., ChemoMetec A/S, Countstar Microscopy Systems, Luminex Corporation, NanoEnTek Inc., Partec GmbH, Advanced Instruments Inc., Analytik Jena AG, Integra Biosciences AG, Meridian Bioscience Inc., Promega Corporation, Sartorius AG

Global Cell Counting Market Trends and Insights

Major companies operating in the cell counting market are focusing on innovative products like the BD FACSDiscover S8 spectral cell sorter to better meet the needs of their existing consumers. Spectral cell sorting is a revolutionary approach that sorts cells based on their visual properties by combining superior spectral flow cytometry with high-speed imaging technologies. Unlike classical flow cytometry, which detects particular fluorescent bands, spectral flow cytometry collects the whole spectrum of signals generated by sample arrangements, allowing for multiple parameter sorting. For instance, in May 2023, Becton, Dickinson, and Company, a US-based company that manufactures medical devices, instrument systems, and reagents, launched the BD FACSDiscover S8 Cell Sorter, presenting two game-changing technologies that allow researchers to reveal previously undetectable information about cells in standard flow cytometry investigations. Researchers may examine comprehensive microscopic images of individual cells and sort them at fast rates based on visual criteria to validate findings in real time using BD CellView Image Technology. Researchers may use BD SpectralFX Technology to undertake high-parameter studies with full-spectrum cell sorting and enhanced performance offered by a new flexible optical architecture and system-aware algorithms. The integration of these advancements in the BD FACSDiscover S8 Cell Sorter broadens researchers' capabilities, with the potential to change research and cell-based therapy development in a variety of domains such as drug discovery, immuno-oncology, and genomics.

What Are Latest Mergers And Acquisitions In The Cell Counting Market?

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences, Inc. for an undisclosed amount. This acquisition aims to enhance Cell Microsystems' capabilities in the fields of single-cell analysis and precision medicine. By integrating Fluxion Biosciences' innovative microfluidic technology and expertise in cellular analysis. Fluxion Biosciences, Inc. is a US-based biotechnology company.

Regional Outlook

North America was the largest region in the cell counting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cell Counting Market?

The cell counting market includes revenues earned by entities by direct total, indirect total, direct differential, and indirect differential cell counting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.